SbsungboSB성보

Sbsungbo is loss-making on a trailing basis after a sharp swing from a 2025 profit, with its share price down 20% over the past year.

Sbsungbo, a Korean crop protection and agrochemical maker, reported trailing twelve-month revenue of ₩65.7B to H1 2026 but an operating loss of ₩8.8B and a net loss of ₩13.7B. Its 2025 full-year net income of ₩34.5B looks inconsistent with its operating loss and is not explained in the data. The shares closed at ₩2,245 on 2026-10-19, near the lower half of their 52-week range of ₩2,040 to ₩2,985.

What stands out

• Trailing operating margin is -13.4% and free cash flow is about -₩23.1B, against cash of ₩9.1B and borrowings of ₩35B.
• The 2025 net income of ₩34.5B sits oddly against an operating loss of ₩8.1B; the data does not say what drove the gap, so it should be checked in the filings.
• The stock trades at about 0.3x book value and a 9.1% dividend yield is shown, but the data does not give the dividend amount or history.
• Foreign ownership slipped from 1.1% to 1.0% over 60 days, while retail investors were net buyers over the last 20 days.
• No news headlines were provided, so the picture rests on filings and financial data alone.

What to watch

• The full-year 2026 results and whether the trailing operating loss narrows or persists.
• Further changes in the largest shareholder's holdings, which appear several times in recent filings.
• Cash flow and debt levels, given the negative free cash flow and ₩35B in borrowings.